openPR Logo
Press release

Retinal Vein Occlusion Market Trends: Surge in Anti-VEGF Therapies and Digital Health Tools | Bayer AG, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd

07-16-2025 02:29 PM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research LLP

Retinal Vein Occlusion

Retinal Vein Occlusion

"Retinal Vein Occlusion (RVO) Market reached US$0.93 billion in 2024 and is expected to reach US$2.11 billion by 2033, growing at a CAGR of 9.6% during the forecast period 2025-2033," according to DataM Intelligence.

Emerging companies such as Sunshine Guojian Pharmaceutical (Shanghai), Kodiak Sciences Inc., and Taiwan Liposome Co., Ltd. are bringing innovation to the Retinal Vein Occlusion market with their pipeline of long-acting anti-VEGF biosimilars and advanced liposomal delivery systems. These players are challenging established providers by focusing on regionally tailored R&D, cost-efficient manufacturing, and niche biologic solutions designed for sustained ocular drug delivery.

Download your exclusive sample report today: https://www.datamintelligence.com/download-sample/retinal-vein-occlusion-market?jd

Retinal Vein Occlusion Market M&A & Strategic Collaborations

1. Novartis enters gene therapy partnership for RVO (July 2025) to explore underlying vascular disorder solutions beyond anti-VEGF modalities.
2. Regeneron publishes EYLEA HD Phase III results (June 2025), reinforcing its clinical leadership and informing potential future licensing or distribution deals.
3. Samsung Bioepis secures CHMP's Pavblu biosimilar opinion (June 2025), with plans to bring new ranibizumab biosimilar options for RVO to the EU market.

As per our analysis, these developments highlight the RVO market's focus on next-gen biologics, biosimilar launches, and clinical data sharing partnerships shaping therapeutic evolution.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/retinal-vein-occlusion-market?jd

Key Growth Drivers & Emerging Opportunities in the Retinal Vein Occlusion Market

• Rising incidence of RVO due to diabetes, hypertension, and aging global demographics.
• Regulatory approvals of bispecific antibodies like Vabysmo, enabling extended dosing.
• Integration of AI-powered diagnostics and teleophthalmology platforms-boosting early detection.
• Surge in sustained-release implants and biosimilar anti-VEGF launches is increasing patient compliance.
• Expansion of clinical R&D in gene therapy and personalized ocular treatments opens future avenues.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=retinal-vein-occlusion-market?jd

Regional Market Drivers for Retinal Vein Occlusion

North America leads, supported by advanced healthcare infrastructure, high awareness of eye disease, and reimbursement for cutting-edge RVO treatments.
Europe benefits from approvals of biosimilars (e.g., Pavblu), a strong diagnostic network, and public screening programs.
Asia-Pacific is the fastest-growing region, driven by aging populations, increased healthcare expenditure, and regional R&D.
Latin America, the Middle East & Africa are emerging markets supported by rising ocular disease awareness and expanding access via global health initiatives.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Pipeline Analysis For Drug Discovery
✅ Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Competitive Landscape

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights, and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains, creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Vein Occlusion Market Trends: Surge in Anti-VEGF Therapies and Digital Health Tools | Bayer AG, Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche Ltd here

News-ID: 4106565 • Views:

More Releases from DataM Intelligence 4Market Research LLP

Trauma Fixation Devices Market Outlook: Bioabsorbable Implants, 3D Printing, and Minimally Invasive Solutions | Top Companies are Stryker Corporation, Johnson & Johnson, Cardinal Health Inc.
Trauma Fixation Devices Market Outlook: Bioabsorbable Implants, 3D Printing, and …
Trauma Fixation Devices Market is valued at a significant CAGR during the forecast period (2024-2031). As per DataM Intelligence Database. Trauma Fixation Devices include plates, screws, nails, and external fixators for bone fracture stabilization. Growth is driven by rising orthopedic injuries and surgical procedures. Innovations include bioresorbable implants, minimally invasive solutions, and patient-specific devices. Hospitals and orthopedic clinics are key end-users. Advanced materials improve strength, biocompatibility, and recovery outcomes. Market expansion
Septicemia Diagnostic Testing Market Outlook: Rapid PCR, Biosensors, and Point-of-Care Solutions | Top Players are Diasorin, Abbott, F. Hoffmann-LA Roche Ltd.
Septicemia Diagnostic Testing Market Outlook: Rapid PCR, Biosensors, and Point-o …
Septicemia Diagnostic Testing Market is expected to reach at a CAGR of 13.5 % during the forecast period (2024-2031). Septicemia Diagnostic Testing involves detecting bloodstream infections caused by bacteria or fungi. Growth is driven by rising sepsis prevalence, hospital-acquired infections, and early detection needs. Technologies include PCR, blood culture, and biosensors. Rapid and accurate diagnostics improve patient outcomes and reduce mortality. Hospitals, diagnostic labs, and research centers are key end-users. Innovations
Digital Signature Market Growth Driven by Remote Work, Regulatory Compliance, and SaaS Integration | Adobe Inc, OneSpan, Thales
Digital Signature Market Growth Driven by Remote Work, Regulatory Compliance, an …
Digital Signature Market is valued at at a promising CAGR during the forecast period (2024-2031). The Digital Signature Market enables electronic authentication, document security, and transaction validation. Growth is driven by remote work, e-commerce, and regulatory compliance requirements. It ensures legal enforceability, tamper-proof documentation, and identity verification. Adoption spans banking, legal, healthcare, and government sectors. Cloud-based platforms and blockchain integration enhance security and convenience. Increasing awareness of digital workflows accelerates market
United States Nuclear Reactor Decommissioning Market 2024-2031: Growth Outlook to US$ 94.3 Billion | SNC-Lavalin Group, Westinghouse Electric Company, AECOM orano
United States Nuclear Reactor Decommissioning Market 2024-2031: Growth Outlook t …
Global Nuclear Reactor Decommissioning Market reached US$ 76.5 billion in 2022 and is expected to reach US$ 94.3 billion by 2031, growing with a CAGR of 2.7% during the forecast period 2024-2031. Nuclear Reactor Decommissioning involves safely dismantling nuclear facilities and managing radioactive waste. Growth is driven by aging reactors and stringent safety regulations. Technologies include remote handling, radiation shielding, and waste storage solutions. Regulatory compliance and environmental sustainability are critical

All 5 Releases


More Releases for Retinal

Retinal Disorder Treatment: Core Growth Enabler in the Rising Incidence Of Retin …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Retinal Disorder Treatment Industry Market Size Be by 2025? In past years, the retinal disorder treatment market has witnessed significant growth. The market worth which stood at $12.59 billion in 2024, is expected to surge to $13.69 billion in 2025, approximating a compound annual growth rate
Retinal Biologics Market Size: Targeted Treatments for AMD, DME & Retinal Diseas …
Retinal Biologics Market reached US$ 24.16 Billion in 2024 and is expected to reach US$ 40.46 Billion by 2033, growing at a CAGR of 5.9% during the forecast period 2025-2033. Retinal Biologics Market Report by DataM Intelligence delivers deep insights and analysis into the latest market trends, growth opportunities, and emerging challenges. Designed to help businesses make smarter, faster decisions, our reports combine both data-driven analysis and expert perspectives. At DataM
Key Influencer in the Retinal Disorder Treatment Market 2025: Rising Incidence O …
What combination of drivers is leading to accelerated growth in the retinal disorder treatment market? The escalation in retinal disorder instances is anticipated to fuel the expansion of the retinal disorder treatment market. Retinal diseases are health issues that influence the retina, the light-sensitive tissue at the rear of the eye, potentially leading to vision loss or significant visual impairment. Treatments for retinal disorders, such as laser therapy, vitrectomy, and retinal
Retinal Biologics Market Report 2024 - Retinal Biologics Market Insights, Size A …
"The Business Research Company recently released a comprehensive report on the Global Retinal Biologics Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;